Treatment measures for rectal cancer_Zhengzhou Anus and Intestine Disease Hospital

by noprefect on 2011-05-04 09:04:41

1. Actively treat chronic intestinal lesions, such as colon or rectal polyps, schistosomiasis, bacillary dysentery, amoebas, and chronic ulcerative colitis.

2. Once the diagnosis is confirmed, except for late-stage cases, early surgical treatment should be carried out and primary radical surgery should be attempted.

3. For complete obstruction of colon and sigmoid colon cancer, intestinal decompression surgery and proximal enterostomy should be performed first, followed by radical surgery after 2-3 weeks.

4. For rectal cancer within 8 cm of the anus, the anal canal and surrounding tissues need to be removed together, and an abdominal permanent colostomy should be performed.

5. Chemotherapy drugs such as 5Fu and MMC can be selected.

6. Traditional Chinese medicine (TCM) treatment can be one of the measures in comprehensive treatment, suitable for patients who are not suitable for surgery and radiotherapy/chemotherapy, or those with recurrence after surgery. Hebei Fushan Traditional Chinese Medicine Oncology Hospital has developed cell molecular regulators, including Fushan Shen series preparations (water pills, capsules, oral liquids, etc.) and anti-cancer injections using high-tech achievements. These break the traditional thinking pattern of toxic, killing, and resisting cancer. The drugs themselves have no toxicity and do not produce direct stimulation on tumors. They are clinical applications of cell gene therapy. The principle of their anti-cancer mechanism is: inhibiting the formation of new blood vessel networks in tumors, blocking the nutrient supply of cancer cells, cutting off the metabolic channels of cancer cells, causing the tumor to gradually wither due to lack of nutrition, and gradually become necrotic and degenerative because waste cannot be discharged, without harming normal cells. At the same time, it enhances the body's immune function, promotes the regeneration of the body's anti-cancer immune surveillance system, activates various cancer-killing cells, regulates the cell cycle engine molecules and cell power, restores the normal cycle rhythm of out-of-control cancer cells, and reverses cancer cells. This drug, when used in combination with radiotherapy and chemotherapy, can significantly reduce the toxic side effects of radiotherapy and chemotherapy, and increase the number of white blood cells. Even for late-stage patients who have lost the opportunity for surgery, radiotherapy, and chemotherapy, this drug can control metastasis, alleviate cancer pain, improve symptoms, enhance quality of life, and extend the survival period with cancer.